Addressing Comorbidities in the Diagnosis and Management of Persons with Multiple Sclerosis:
A Resource Guide for Clinicians
Items marked with * require a response.
Choose the best answer for each question below.
Which comorbidity has the highest prevalence in the MS population overall?
A recent retrospective cohort study showed that each additional comorbidity was associated with how much reduction in the likelihood that a person initiated a DMT at one year after MS diagnosis?
Ideally, how frequently should clinicians screen for psychiatric disorders in persons with MS?
Once at initial diagnosis
At every clinic visit
Which team-based approach has been shown to increase the acceptance of therapy intensification for managing vascular and metabolic comorbidities in persons with an autoimmune disease (rheumatoid arthritis)?
Shared medical appointments
Using a transition of care coordinator
Co-location of clinic offices
Compared with untreated individuals, those with RRMS who were obese and had metabolic syndrome showed improvement in total and LDL cholesterol, triglycerides, and systolic blood pressure after 24 months of treatment with which therapy?
In an evidence-based guideline on the management of psychiatric disorders in MS, the American Academy of Neurology recommends considering which nonpharmacologic intervention for treating depressive symptoms in MS?
Cognitive behavioral therapy